Last update Jan. 30, 2021
Very Low Risk
Short-acting beta-adrenergic bronchodilator, similar in characteristics to salbutamol.
Indicated in the treatment of asthma.
Administration preferably inhaled (also oral or intravenous).
It is excreted into breast milk in clinically non-significant amount (Lindberg 1984, Lonnerholm 1982, Boreus 1982) and neither clinical nor development problems were observed in infants whose mothers were treated with oral terbutaline (Lindberg 1984, Lonnerholm 1982, Boreus 1982) .
Plasma levels of these infants were undetectable or very low (Lindberg 1984, Lonnerholm 1982).
Preferable preparations are inhaled bronchodilators since <10% of the dose is absorbed.
Several medical societies, experts authors and expert consensus consider the use of inhaled bronchodilators to be safe during breastfeeding (Hale, Lactmed, Amir 2011, National Asthma 2004, Nelson 2001, Ellsworth 1994).
American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).
We do not have alternatives for 2-tert-Butylamino-1-(3,5-dihydroxyphenyl)ethanol sulphate since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM